Annual Total Assets
$32.69 M
-$31.47 M-49.05%
30 September 2022
Summary:
NeuBase Therapeutics annual total assets is currently $32.69 million, with the most recent change of -$31.47 million (-49.05%) on 30 September 2022. During the last 3 years, it has fallen by -$31.47 million (-49.05%).NBSE Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$18.62 M
-$3.71 M-16.62%
30 September 2023
Summary:
NeuBase Therapeutics quarterly total assets is currently $18.62 million, with the most recent change of -$3.71 million (-16.62%) on 30 September 2023.NBSE Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -49.0% | -71.0% |
| 5 y5 years | +160.9% | +48.6% |
NBSE Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -49.0% | -73.1% |
NeuBase Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $18.62 M(-16.6%) |
| June 2023 | - | $22.33 M(+4.1%) |
| Mar 2023 | - | $21.46 M(-16.1%) |
| Dec 2022 | - | $25.58 M(-21.7%) |
| Sept 2022 | $32.69 M(-49.0%) | $32.69 M(-18.3%) |
| June 2022 | - | $40.00 M(-18.1%) |
| Mar 2022 | - | $48.81 M(-14.4%) |
| Dec 2021 | - | $57.04 M(-11.1%) |
| Sept 2021 | $64.17 M(+86.3%) | $64.17 M(-7.4%) |
| June 2021 | - | $69.32 M(+152.3%) |
| Mar 2021 | - | $27.47 M(-10.7%) |
| Dec 2020 | - | $30.76 M(-10.7%) |
| Sept 2020 | $34.44 M(+174.9%) | $34.44 M(-9.7%) |
| June 2020 | - | $38.16 M(+394.5%) |
| Mar 2020 | - | $7.72 M(-21.9%) |
| Dec 2019 | - | $9.88 M(-21.2%) |
| Sept 2019 | $12.53 M(+4920.6%) | $12.53 M(+44.2%) |
| June 2019 | - | $8.69 M(-9.7%) |
| Mar 2019 | - | $9.63 M(-9.8%) |
| Dec 2018 | - | $10.67 M(+4176.4%) |
| Sept 2018 | $249.60 K(-99.1%) | $249.60 K(-98.6%) |
| June 2018 | - | $18.07 M(-6.8%) |
| Mar 2018 | - | $19.39 M(-17.3%) |
| Dec 2017 | - | $23.43 M(-16.1%) |
| Sept 2017 | $27.93 M(-5.1%) | $27.93 M(-17.2%) |
| June 2017 | - | $33.72 M(+31.4%) |
| Mar 2017 | - | $25.67 M(-13.7%) |
| Dec 2016 | - | $29.73 M(+1.0%) |
| Sept 2016 | $29.45 M(-36.5%) | $29.45 M(-14.2%) |
| June 2016 | - | $34.31 M(-12.2%) |
| Mar 2016 | - | $39.09 M(-11.5%) |
| Dec 2015 | - | $44.15 M(-4.8%) |
| Sept 2015 | $46.37 M(+44.8%) | $46.37 M(-6.0%) |
| June 2015 | - | $49.34 M(-4.1%) |
| Mar 2015 | - | $51.44 M(+75.1%) |
| Dec 2014 | - | $29.38 M(-8.3%) |
| Sept 2014 | $32.03 M(+457.5%) | $32.03 M(-9.9%) |
| June 2014 | - | $35.55 M(+738.1%) |
| Mar 2014 | - | $4.24 M(-7.6%) |
| Dec 2013 | - | $4.59 M(-20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | $5.74 M(+63.3%) | $5.74 M(-16.3%) |
| June 2013 | - | $6.86 M(+164.2%) |
| Mar 2013 | - | $2.60 M(-11.2%) |
| Dec 2012 | - | $2.92 M(-16.9%) |
| Sept 2012 | $3.52 M(+149.0%) | $3.52 M(+35.4%) |
| June 2012 | - | $2.60 M(+34.8%) |
| Mar 2012 | - | $1.93 M(-7.1%) |
| Dec 2011 | - | $2.07 M(+46.8%) |
| Sept 2011 | $1.41 M(+0.1%) | $1.41 M(-14.5%) |
| June 2011 | - | $1.65 M(-14.1%) |
| Mar 2011 | - | $1.92 M(+20.6%) |
| Dec 2010 | - | $1.60 M(+13.0%) |
| Sept 2010 | $1.41 M(+14.7%) | $1.41 M(-6.6%) |
| June 2010 | - | $1.51 M(-8.8%) |
| Mar 2010 | - | $1.66 M(+14.4%) |
| Dec 2009 | - | $1.45 M(+17.8%) |
| Sept 2009 | $1.23 M(+580.6%) | $1.23 M(-8.7%) |
| June 2009 | - | $1.35 M(+89.6%) |
| Mar 2009 | - | $711.00 K(+546.4%) |
| Dec 2008 | - | $110.00 K(-39.2%) |
| Sept 2008 | $180.80 K(-74.2%) | $180.80 K(-25.3%) |
| June 2008 | - | $242.00 K(-32.4%) |
| Mar 2008 | - | $358.00 K(-51.9%) |
| Dec 2007 | - | $744.00 K(+6.0%) |
| Sept 2007 | $702.00 K(+81.3%) | $702.00 K(-29.9%) |
| June 2007 | - | $1.00 M(-80.9%) |
| Mar 2007 | - | $5.24 M(+1251.7%) |
| Dec 2006 | $387.30 K(-77.7%) | $387.30 K(-5.0%) |
| Sept 2006 | - | $407.50 K(-0.5%) |
| June 2006 | - | $409.50 K(-77.5%) |
| Mar 2006 | - | $1.82 M(+4.8%) |
| Dec 2005 | $1.73 M(-5.1%) | $1.73 M(-17.8%) |
| Sept 2005 | - | $2.11 M(+4.0%) |
| June 2005 | - | $2.03 M(+1.3%) |
| Mar 2005 | - | $2.00 M(+9.6%) |
| Dec 2004 | $1.83 M(+40.6%) | $1.83 M(+8.7%) |
| Sept 2004 | - | $1.68 M(+8.7%) |
| June 2004 | - | $1.55 M(+7.4%) |
| Mar 2004 | - | $1.44 M |
| Dec 2003 | $1.30 M | - |
FAQ
- What is NeuBase Therapeutics annual total assets?
- What is the all time high annual total assets for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for NeuBase Therapeutics?
What is NeuBase Therapeutics annual total assets?
The current annual total assets of NBSE is $32.69 M
What is the all time high annual total assets for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual total assets is $64.17 M
What is NeuBase Therapeutics quarterly total assets?
The current quarterly total assets of NBSE is $18.62 M
What is the all time high quarterly total assets for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly total assets is $69.32 M